Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Rongjun Zou(Guangzhou University of Chinese Medicine), Li Ma(Guangzhou Women and Children Medical Center)
Cardiovascular Diabetology
June 15, 2022
Cited by 122


Related Papers